Oct. 13 (Fri.) ,2017 15:00-16:30

Annex Hall

Simultaneous Interpretation

【O-19】 Emerging technologies and products in Regenerative Medicine

Cutting-edge R&D of RM products will be presented by the representatives of venture companies in Japan, Australia and UK


Yoshikazu Morishita

Chair, Public Affairs Committee, Forum for Innovative Regenerative Medicine

Developing the World’s First iPSC-derived MSC Therapeutic Product

Ross Macdonald

Chief Executive Officer, Cynata Therapeutics

Commercial-scale stem cell therapies for stroke disability and retinal diseases

John Sinden

CSO and Founder, ReNeuron

Next generation therapy for dialysis patients using iPS cell-derived regenerated kidney

Yokoo Takashi

Professor, Department of Internal Medicine, Jikei Univ. School of Medicine

Close Window